Indication

Recurrent Clostridioides difficile infection

Recurrent *Clostridioides difficile* infection is a gastrointestinal disease characterized by the return of symptom-producing colonic infection within eight weeks following the successful resolution of an earlier episode. Read more about Recurrent Clostridioides difficile infection

1 drugs 1 manufacturers

Drugs that treat it

Common Recurrent Clostridioides difficile infection therapies.

Showing 1–1 of 1 drugs

Sort

REBYOTA (fecal microbiota, live-jslm)

FECAL MICROBIOTA THERAPIES·RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION

FERRING LABS

Filter & compare in the drug finder →Opens the drug finder with Recurrent Clostridioides difficile infection preselected.

News & literature

Coming soon

Related codes

Coming soon

About Recurrent Clostridioides difficile infection.

It most commonly affects older adults, individuals exposed to broad-spectrum antibiotics, and hospitalized or immunocompromised patients.

Pathophysiologically driven by persistent gut microbiota dysbiosis and impaired mucosal defense, residual endospores germinate into toxin-producing vegetative bacilli that induce colonic inflammation, causing watery diarrhea, abdominal pain, fever, and potential progression to pseudomembranous colitis or toxic megacolon.

nih.gov
Recurrent *Clostridioides difficile* infection is a gastrointestinal disease characterized by the return of symptom-producing colonic infection within eight weeks following the successful resolution of an earlier episode It most commonly affects older adults, individuals exposed to broad-spectrum antibiotics, and hospitalized or immunocompromised patients Pathophysiologically driven by persistent gut microbiota dysbiosis and impaired mucosal defense, residual endospores germinate into toxin-prod...
nih.gov
Recurrent *Clostridioides difficile* infection is a gastrointestinal disease characterized by the return of symptom-producing colonic infection within eight weeks following the successful resolution of an earlier episode
ccjm.org
Recurrent *Clostridioides difficile* infection is a gastrointestinal disease characterized by the return of symptom-producing colonic infection within eight weeks following the successful resolution of an earlier episode Pathophysiologically driven by persistent gut microbiota dysbiosis and impaired mucosal defense, residual endospores germinate into toxin-producing vegetative bacilli that induce colonic inflammation, causing watery diarrhea, abdominal pain, fever, and potential progression to p...
cdc.gov
It most commonly affects older adults, individuals exposed to broad-spectrum antibiotics, and hospitalized or immunocompromised patients Pathophysiologically driven by persistent gut microbiota dysbiosis and impaired mucosal defense, residual endospores germinate into toxin-producing vegetative bacilli that induce colonic inflammation, causing watery diarrhea, abdominal pain, fever, and potential progression to pseudomembranous colitis or toxic megacolon
nih.gov
Pathophysiologically driven by persistent gut microbiota dysbiosis and impaired mucosal defense, residual endospores germinate into toxin-producing vegetative bacilli that induce colonic inflammation, causing watery diarrhea, abdominal pain, fever, and potential progression to pseudomembranous colitis or toxic megacolon

Personalize your experience

Follow Recurrent Clostridioides difficile infection and get updates as they land.

Create a free account

Already a member? Sign in

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it